
AKT Kinase Pathway: A Leading Target in Cancer Research
AKT1, a serine/threonine-protein kinase also known as AKT kinase, is involved in the regulation of various signalling downstream pathways including metabolism, cell proliferation, survival, …
AKT kinases as therapeutic targets | Journal of Experimental
Nov 29, 2024 · AKT, or protein kinase B, is a central node of the PI3K signaling pathway that is pivotal for a range of normal cellular physiologies that also underlie several pathological …
AKT/PKB Signaling: Navigating the Network - PMC
In the context of a network view of AKT signaling, we highlight the three best-established downstream targets of AKT, which are also key signaling nodes that integrate AKT signaling …
Targeting AKT for cancer therapy - PMC - PubMed Central (PMC)
Targeted therapies in cancer aim to inhibit specific molecular targets responsible for enhanced tumor growth. AKT/PKB (protein kinase B) is a serine threonine kinase involved in several …
AKT as a Therapeutic Target for Cancer
Mar 15, 2019 · V-akt murine thymoma viral oncogene homolog (AKT) plays a major role in the PI3K/AKT signaling pathways. AKT is activated by PI3K or phosphoinositide-dependent …
A systematic molecular and pharmacologic evaluation of AKT …
May 22, 2020 · AKT, a critical effector of the phosphoinositide 3-kinase (PI3K) signalling cascade, is an intensely pursued therapeutic target in oncology. Two distinct classes of AKT inhibitors …
AKT signaling in normal and malignant cells | Oncogene - Nature
Nov 14, 2005 · AKT/protein kinase B (PKB) is a cardinal node in diverse signaling cascades important in both normal cellular physiology and various disease states. AKT signaling …
PI3K/Akt: getting it right matters | Oncogene - Nature
Oct 27, 2008 · The Akt serine/threonine kinase (also called protein kinase B) has emerged as a critical signaling molecule within eukaryotic cells. Significant progress has been made in …
Akt: a key transducer in cancer - PMC - PubMed Central (PMC)
Thus, the systematic versus cell-autonomous deletion of Akt isoforms could result in distinct impacts on cancer phenotypes. In this review, we summarized the recent provocative findings …
Targeting Akt in cancer for precision therapy
Aug 21, 2021 · Here, we highlight recent progress of Akt signaling pathway, review the up-to-date data from clinical studies of Akt inhibitors and discuss the potential biomarkers that may help …
- Some results have been removed